TY - JOUR
TI - Daratumumab-based regimens are highly effective and well tolerated in relapsed or refractory multiple myeloma regardless of patient age: subgroup analysis of the phase 3 CASTOR and POLLUX studies
AU - Mateos, Maria-Victoria
AU - Spencer, Andrew
AU - Nooka, Ajay K
AU - Pour, Ludek
AU - Weisel, Katja
AU - Cavo, Michele
AU - Laubach, Jacob P
AU - Cook, Gordon
AU - Iida, Shinsuke
AU - Benboubker, Lotfi
AU - others
JO - Haematologica-the hematology journal
PY - 2020
VL - 105
TODO - 2
SP - 468
PB - Ferrata Storti Foundation
SN - null
TODO - null
TODO - null
TODO - null
ER -